A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003)

Clinical trial NCT00848718 · COMPLETED

Trial details

NCT number: NCT00848718
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced, Metastatic Solid Tumors

Start date: 2009-03-17
Primary completion: 2011-05-19
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.